2019
NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease
Malczewska A, Oberg K, Bodei L, Aslanian H, Lewczuk A, Filosso PL, Wójcik-Giertuga M, Rydel M, Zielińska-Leś I, Walter A, Suarez A, Kolasińska-Ćwikła A, Roffinella M, Jamidar P, Ziora D, Czyżewski D, Kos-Kudła B, Ćwikła J. NETest Liquid Biopsy Is Diagnostic of Lung Neuroendocrine Tumors and Identifies Progressive Disease. Neuroendocrinology 2019, 108: 219-231. PMID: 30654372, PMCID: PMC7472425, DOI: 10.1159/000497037.Peer-Reviewed Original ResearchConceptsSmall cell lung cancerLarge cell neuroendocrine carcinomaSquamous cell carcinomaIdiopathic pulmonary fibrosisBronchopulmonary carcinoidsNETest levelsLung cancerAtypical carcinoidLiquid biopsyLung neuroendocrine tumorsRECIST 1.1Stable diseaseMetastatic diseaseProgressive diseaseStudy cohortClinical progressionPulmonary fibrosisCell carcinomaNeuroendocrine carcinomaNeuroendocrine tumorsLung neoplasiaHealthy controlsNeuroendocrine neoplasiaBlinded studyBlood samples
2011
Tu1554 Interobserver Agreement for Confocal Imaging of Ampullary Lesions: A Multicenter Single Blinded Study
Bakhru M, Sethi A, Jamidar P, Singh S, Kwon R, Siddiqui U, Sawhney M, Talreja J, Gaidhane M, Sauer B, Kahaleh M. Tu1554 Interobserver Agreement for Confocal Imaging of Ampullary Lesions: A Multicenter Single Blinded Study. Gastrointestinal Endoscopy 2011, 73: ab445. DOI: 10.1016/j.gie.2011.03.1046.Peer-Reviewed Original Research